Targeting pancreatic cancer with TCR-engineered T cells

被引：0
|
作者：
Greenberg, Philip D. [1 ]
Anderson, Kristin G. [1 ]
Egan, Dan [1 ]
Hingorani, Sunil R. [1 ]
Nezi, Luigi [2 ]
Manzo, Teresa [2 ]
Oda, Shannon K. [1 ]
Paulson, Kelly G. [1 ]
Perret, Rachel [1 ]
Schmidt, Leah [1 ]
Schmitt, Tom M. [1 ]
Stromnes, Ingunn M. [3 ]
Chapuis, Aude G. [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[2] European Inst Oncol IEO, Milan, Italy
[3] Univ Minnesota, Seattle, WA USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 24期
关键词：
D O I：
10.1158/1538-7445.PANCA19-I11
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
I11
引用
收藏
页数：2
相关论文
共 50 条
  • [1] TCR-engineered T cells get personal
    Villanueva, M. Teresa
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (01) : 18 - 18
  • [2] TCR-engineered T cells get personal
    M. Teresa Villanueva
    [J]. Nature Reviews Drug Discovery, 2023, 22 : 18 - 18
  • [3] Emerging Strategies in TCR-Engineered T Cells
    Wei, Fang
    Cheng, Xiao-Xia
    Xue, John Zhao
    Xue, Shao-An
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
    Shafer, Paul
    Kelly, Lauren M.
    Hoyos, Valentina
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [5] TCR-Engineered, Customized, Antitumor T Cells for Cancer Immunotherapy: Advantages and Limitations
    Chhabra, Arvind
    [J]. THESCIENTIFICWORLDJOURNAL, 2011, 11 : 121 - 129
  • [6] TCR-engineered T cells to treat tumors: Seeing but not touching?
    Debets, Reno
    Donnadieu, Emmanuel
    Chouaib, Salem
    Coukos, George
    [J]. SEMINARS IN IMMUNOLOGY, 2016, 28 (01) : 10 - 21
  • [7] TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells
    Delfanti, Gloria
    Cortesi, Filippo
    Perini, Alessandra
    Antonini, Gaia
    Azzimonti, Laura
    de Lalla, Claudia
    Garavaglia, Claudio
    Squadrito, Mario L.
    Fedeli, Maya
    Consonni, Michela
    Sesana, Silvia
    Re, Francesca
    Shen, Haifa
    Dellabona, Paolo
    Casorati, Giulia
    [J]. SCIENCE IMMUNOLOGY, 2022, 8 (90)
  • [8] ACTALLO®: USING TCR-ENGINEERED ALLOGENEIC GAMMA-DELTA T CELLS TO TREAT CANCER
    Mata, M.
    Kalra, M.
    Coughlin, Z.
    Nowicka, A.
    Pawlowski, N.
    Schwoebel, F.
    Alten, L.
    Kuttruff-Coqui, S.
    Missel, S.
    Hilf, N.
    Weinschenk, T.
    Singh, H.
    Dao, M.
    Bulliard, Y.
    Walter, S.
    [J]. HUMAN GENE THERAPY, 2019, 30 (12) : A5 - A6
  • [9] Generation of TCR-Engineered T Cells and Their Use To Control the Performance of T Cell Assays
    Bidmon, Nicole
    Attig, Sebastian
    Rae, Richard
    Schroeder, Helene
    Omokoko, Tana A.
    Simon, Petra
    Kuhn, Andreas N.
    Kreiter, Sebastian
    Sahin, Ugur
    Gouttefangeas, Cecile
    van der Burg, Sjoerd H.
    Britten, Cedrik M.
    [J]. JOURNAL OF IMMUNOLOGY, 2015, 194 (12): : 6177 - 6189
  • [10] Automated Manufacture of dNPM1 TCR-Engineered T Cells for Therapy
    Ogusuku, Isabella Elias Yonezawa
    Herbel, Vera
    Lennartz, Simon
    Fabian, Caroline
    Brandes, Caroline
    Teppert, Karin
    Barth, Carola
    Veld, Sabrina
    Hageman, Lois
    Hoogstraten, Conny
    Koutsoumpli, Georgia
    Griffioen, Marieke
    Schaser, Thomas
    de Groot, Rosa
    Johnston, Ian
    Lock, Dominik
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 546 - 546
12345